About this trial
This study aims to investigate the placebo (PLA) effect on physical performance across different sports disciplines in real-world, field-based settings. The study investigates how participant expectations and beliefs regarding caffeine (CAF) intake influence physical performance and psychomotor function outside the controlled laboratory environment. Healthy, physically active adults (n = 120) from diverse sports backgrounds will be randomly assigned to receive caffeine, placebo, or no intervention. Participants will perform discipline-specific field exercise tests (e.g., running-based protocols or repeated sprint protocols) while physiological responses are monitored using wearable technology. Physical performance outcomes and psychomotor responses will be analyzed to evaluate the real-world impact of the placebo effect and to distinguish the pharmacological effects of caffeine from those driven by psychological expectations across different athletic settings.
Eligibility criteria
Qualifiers
Age between 20 and 35 years,
Healthy adults,
Regular physical activity,
Normal or corrected-to-normal vision,
Disqualifiers
History of neurological, psychiatric, cardiovascular, or metabolic disorders,
Current use of medication or supplements affecting the central nervous system,
Musculoskeletal injuries that would impair physical performance,
No habitual caffeine consumption or severe negative side effects of caffeine,
Trial design
Treatments tested in this trial
- Caffeine (6mg/kg)
- Placebo (Starch capsule)
- Sham (No Treatment)